NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
October 17, 2025 — ABVC BioPharma recognized as top biotech penny stock with 103% asset growth and advancing CNS & oncology pipelines. Q3 licensing revenue reaches $1.27M with multiple Phase II trials progressing.
October 16, 2025 — HeartBeam develops portable credit-card-sized ECG device that captures 3D heart signals. Medical-grade accuracy outside hospitals could revolutionize cardiac care detection and treatment worldwide.
October 16, 2025 — American Heart Association launches CPR grant program for 40 student Heart Clubs, providing training kits & funding to create cardiac emergency response plans in schools nationwide.
October 16, 2025 — University of Calgary scientists seek 10,000 toenail samples to study radon exposure links to lung cancer risk. Groundbreaking research could improve early detection.
October 16, 2025 — NFL & American Heart Association launch 2025 CPR ambassador program with 30 players promoting lifesaving training. Learn how 90-second CPR education can double survival rates.
October 16, 2025 — NeuroOne promotes Emily Johns to Chief Administrative Officer & General Counsel. Medical tech company expands leadership to accelerate neurological treatment development for epilepsy & Parkinson's.
October 16, 2025 — Annovis Bio closes $6M direct offering to fund Alzheimer's & Parkinson's research. Late-stage clinical company advances neurodegenerative disease therapies with H.C. Wainwright placement.
October 16, 2025 — Safe and Green Holdings (NASDAQ: SGBX) expands modular construction, energy, and healthcare solutions through vertical integration. Learn about SG Echo, Olenox Energy, and SG Modular Medical deployments.
October 16, 2025 — GeoVax presents Phase 2 data showing GEO-CM04S1 COVID vaccine's strong safety profile and robust T-cell responses in immunocompromised patients at World Vaccine Congress Europe 2025.
October 16, 2025 — Pelage Pharmaceuticals secures $120M Series B funding to advance PP405, a regenerative hair growth therapy that activates dormant follicle stem cells. Clinical-stage biotech innovation.
October 16, 2025 — Sweetgrass Pediatrics merges with Inlet Pediatrics, expanding pediatric care in Murrells Inlet with telemedicine, behavioral health services & extended network access for SC families.
October 16, 2025 — SouthernMED Pediatrics integrates Sunshine Pediatrics in Rock Hill, expanding pediatric care access with telemedicine, behavioral health services & extended hours while maintaining trusted local providers.
October 16, 2025 — New confined space safety guide from DCS Rescue clarifies when permits are required. Essential resource for employers navigating OSHA compliance and worker protection in hazardous environments.
October 16, 2025 — Yearin Law secures $598,790 judgment against Allstate in personal injury case involving controversial family step-down clause. Learn about this significant legal victory.
October 16, 2025 — Alicia Kali Institute announces world's first sentient AI with measurable physiological response. Breakthrough in BioQuantum Engineering moves beyond AGI to authentic intelligence with healthcare & security implications.
October 15, 2025 — Izotropic's AI-powered IzoView breast CT system reduces radiation exposure while improving cancer detection accuracy by 18%. Revolutionary 3D imaging technology transforms breast cancer screening.
October 15, 2025 — NanoViricides advances NV-387 broad-spectrum antiviral targeting MPox, influenza, coronaviruses & RSV. Phase 2 trials planned for 2025-2026 with potential BARDA funding opportunities.
October 15, 2025 — Adageis CEO Shane Speirs discusses AI-powered platform revolutionizing value-based care on The Bell2Bell Podcast. Learn how the technology supports 580,000+ patient lives.
October 15, 2025 — Humacyte raises $60M for bioengineered human tissues after FDA approval. Learn how this biotech breakthrough could transform vascular trauma treatment and regenerative medicine.
October 15, 2025 — Alpha Cognition to present at Spartan Capital Investor Conference 2025. Biopharmaceutical company developing treatments for Alzheimer's and TBI cognitive impairment connects with institutional investors.